Donald Trump's proposed policies are likely to give the US dollar a boost during his second term, but a stronger US currency ...

Indexes traded mixed on Thursday as traders assessed new inflation data and waited for remarks from Federal Reserve Chair ...

Oppenheimer analyst Rick Schafer raised the firm’s price target on Nvidia (NVDA) to $175 from $150 and keeps an Outperform rating on the ...

HSBC raised the firm’s price target on Nvidia (NVDA) to $200 from $145 and keeps a Buy rating on the shares. Published first on TheFly ...

Reported record backlog of $316.2 million, the highest quarter ending backlog in Company history driven primarily by Intuitive Machines’ fourth NASA CLPS award; backlog does not yet include the full ...

Raising and narrowing 2024 guidance ranges: Adjusted EBITDA of $750 to $780 million and Adjusted Free Cash Flow of $265 to $285 million. Reaffirming 2025 guidance ranges: Adjusted EBITDA of $925 to $1 ...

Acelrx Pharmaceuticals ( (TLPH)) has released its Q3 earnings. Here is a breakdown of the information Acelrx Pharmaceuticals presented to its investors. Talphera, Inc. is a specialty pharmaceutical ...

HIGHLIGHTS:Production guidance for July-December of 19,350 - 19,750 Gold Ounces and 20,000 - 20,250 Gold Equivalent OuncesCash Cost guidance of ...

New York, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tekumo Inc. (TKMO or the "Company") announces its preliminary results for Q3, 2024. Revenue for the first three quarters of 2024 increased 218% over the ...

Citi lowered the firm’s price target on Kuehne & Nagel to CHF 188 from CHF 205 and keeps a Sell rating on the shares. Published ...

Adaptimmune Therapeutics Plc. ( (ADAP) ) has released its Q3 earnings. Here is a breakdown of the information Adaptimmune Therapeutics Plc.

Protean Energy Limited (AU:POW) has released an update. Protean Energy Limited has announced that all resolutions at its recent Annual General ...